DiNuzzo Private Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

DiNuzzo Private Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.4K	Hold	27	–	–	﹤0.01%	247
2026 Q1	$12.1K	Buy	27 +1	+4%	+$466	﹤0.01%	252
2025 Q4	$11.8K	Buy	26 +3	+13%	+$1.29K	﹤0.01%	253
2025 Q3	$8.99K	Sell	23 -2	-8%	-$836	﹤0.01%	281
2025 Q2	$11.1K	Sell	25 -1	-4%	-$461	﹤0.01%	245
2025 Q1	$12.6K	Hold	26	–	–	﹤0.01%	217
2024 Q4	$10.5K	Sell	26 -1	-4%	-$464	﹤0.01%	239
2024 Q3	$12.6K	Hold	27	–	–	﹤0.01%	223
2024 Q2	$12.7K	Buy	27 +11	+69%	+$4.78K	﹤0.01%	171
2024 Q1	$6.69K	Sell	16 -1	-6%	-$423	﹤0.01%	221
2023 Q4	$6.92K	Buy	+17	New	+$6.28K	﹤0.01%	202

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DiNuzzo Private Wealth's VRTX Position: Q2 2026 in Review

DiNuzzo Private Wealth held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 27 shares worth $13.4K. The position accounts for ﹤0.01% of the portfolio, ranked #247.

DiNuzzo Private Wealth first reported a position in VRTX in Q4 2023 and has held it in 11 quarters since. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

DiNuzzo Private Wealth held 27 shares of Vertex Pharmaceuticals worth $13.4K as of Q2 2026.
DiNuzzo Private Wealth left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up ﹤0.01% of DiNuzzo Private Wealth's portfolio in Q2 2026, its #247 holding.
DiNuzzo Private Wealth first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on DiNuzzo Private Wealth's 13F filing for Q2 2026, filed 10 Jul 2026.